首页 › 肝癌（肝细胞癌） › 宾夕法尼亚州 › Philadelphia
Philadelphia PA 肝癌（肝细胞癌）临床试验
16项针对 肝癌（肝细胞癌）的研究正在 Philadelphia及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #98, Philadelphia
National Liver Cancer Screening Trial
招募中4 期
- University of Pennsylvania, Philadelphia
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
招募中3 期
- Research Site, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
招募中1/2 期
- Children's Hospital of Philadelphia, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
招募中3 期
- Christiana Care Health System-Concord Health Center, Chadds Ford · 距离 23 英里
- Christiana Care Health System-Wilmington Hospital, Wilmington · 距离 25 英里
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- Thomas Jefferson University, Philadelphia
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
招募中
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Y-90 Treatment Response Using Transarterial Radioembolization
招募中2 期
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
招募中1/2 期
- University of Pennsylvania, Philadelphia
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
招募中1/2 期
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
招募中2 期
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
SBRT With Atezo/Bev for HCC
招募中1 期
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
招募中观察性研究
- Thomas Jefferson Hospital, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
招募中4 期
- Albert Einstein Healthcare Network, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Philadelphia
其他城市的 肝癌（肝细胞癌）试验
- Houston, TX31 项研究
- New York City, NY24 项研究
- Dallas, TX19 项研究
- Los Angeles, CA19 项研究
- Boston, MA18 项研究
- Cleveland, OH18 项研究
- Chicago, IL16 项研究
- Pittsburgh, PA15 项研究
- San Francisco, CA14 项研究
- Orange, CA14 项研究
- Jacksonville, FL14 项研究
- San Antonio, TX13 项研究
Philadelphia的其他研究
- 癌症（所有类型）59 项研究
- 乳腺癌56 项研究
- 非小细胞肺癌51 项研究
- 转移性癌症46 项研究
- 前列腺癌44 项研究
- 结直肠癌44 项研究
- 卵巢癌44 项研究
- 肺癌36 项研究
- 急性髓系白血病34 项研究
- 心力衰竭31 项研究
- 子宫内膜癌28 项研究
- 抑郁症26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。